Barbara R. Tschida

1.1k total citations
19 papers, 705 citations indexed

About

Barbara R. Tschida is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Barbara R. Tschida has authored 19 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Barbara R. Tschida's work include Sarcoma Diagnosis and Treatment (4 papers), CRISPR and Genetic Engineering (4 papers) and Neurofibromatosis and Schwannoma Cases (4 papers). Barbara R. Tschida is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), CRISPR and Genetic Engineering (4 papers) and Neurofibromatosis and Schwannoma Cases (4 papers). Barbara R. Tschida collaborates with scholars based in United States, Hong Kong and Spain. Barbara R. Tschida's co-authors include David A. Largaespada, Vincent W. Keng, Branden S. Moriarity, Jason Bell, Jesse D. Riordan, Adam J. Dupuy, Christiane B. Knobbe‐Thomsen, Jelena Belic, Volker Hovestadt and Peter Lichter and has published in prestigious journals such as Nature Communications, Molecular Cell and Hepatology.

In The Last Decade

Barbara R. Tschida

18 papers receiving 697 citations

Peers

Barbara R. Tschida
Teresa S. Hyun United States
Richard Torres United States
Andrew Mancini United States
N Shimizu Japan
Nobuaki Akakura United States
Teresa S. Hyun United States
Barbara R. Tschida
Citations per year, relative to Barbara R. Tschida Barbara R. Tschida (= 1×) peers Teresa S. Hyun

Countries citing papers authored by Barbara R. Tschida

Since Specialization
Citations

This map shows the geographic impact of Barbara R. Tschida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara R. Tschida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara R. Tschida more than expected).

Fields of papers citing papers by Barbara R. Tschida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara R. Tschida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara R. Tschida. The network helps show where Barbara R. Tschida may publish in the future.

Co-authorship network of co-authors of Barbara R. Tschida

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara R. Tschida. A scholar is included among the top collaborators of Barbara R. Tschida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara R. Tschida. Barbara R. Tschida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tschida, Barbara R., Maryam Aftabizadeh, Eric C. Holland, et al.. (2025). Abstract 6511: Immunocompetent large animal model of mesenchymal glioblastoma achieved through somatic gene editing technology. Cancer Research. 85(8_Supplement_1). 6511–6511.
2.
Watson, Adrienne L., et al.. (2022). MODL-15. BRINGING PRECISION MEDICINE TO GLIOBLASTOMA PATIENTS BY MODELING MOLECULAR TUMOR SUBTYPES IN IMMUNOCOMPETENT SWINE FOR THERAPEUTIC AND BIOMARKER DEVELOPMENT. Neuro-Oncology. 24(Supplement_7). vii294–vii294. 1 indexed citations
3.
Coutts, Alexander, Barbara R. Tschida, Mark N. Kirstein, et al.. (2021). Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo. Neuro-Oncology Advances. 3(1). vdab020–vdab020. 6 indexed citations
4.
Tschida, Barbara R., Cynthia H. Chiu, Michael A. Linden, et al.. (2020). ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis. JHEP Reports. 3(2). 100223–100223. 19 indexed citations
5.
Qin, Yuan, Barbara R. Tschida, Ben Staal, et al.. (2020). Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice. Neuro-Oncology Advances. 2(1). vdaa067–vdaa067. 8 indexed citations
6.
Tschida, Barbara R., Tung-Ting Sham, Branden S. Moriarity, et al.. (2019). HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism. Molecular Cancer Research. 17(7). 1582–1593. 27 indexed citations
7.
Conboy, Caitlin B., Barbara R. Tschida, Gabriel Kaufmann, et al.. (2019). R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner. Hepatology Communications. 3(11). 1496–1509. 20 indexed citations
8.
Tschida, Barbara R., Nuri A. Temiz, Jesse D. Riordan, et al.. (2017). Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors. Cancer Research. 77(23). 6576–6588. 34 indexed citations
9.
Riordan, Jesse D., Barbara R. Tschida, Vincent W. Keng, et al.. (2017). Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice. Hepatology. 67(3). 924–939. 33 indexed citations
10.
Kim, Kwan‐Hyun, Barbara R. Tschida, Zohar Sachs, et al.. (2016). mTORC1 Coordinates Protein Synthesis and Immunoproteasome Formation via PRAS40 to Prevent Accumulation of Protein Stress. Molecular Cell. 61(4). 625–639. 56 indexed citations
11.
Zuckermann, Marc, Volker Hovestadt, Christiane B. Knobbe‐Thomsen, et al.. (2015). Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nature Communications. 6(1). 7391–7391. 220 indexed citations
12.
Zuckermann, Marc, Volker Hovestadt, Christiane B. Knobbe‐Thomsen, et al.. (2015). Abstract PR02: Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modeling. Cancer Research. 75(23_Supplement). PR02–PR02. 1 indexed citations
13.
Tschida, Barbara R., David A. Largaespada, & Vincent W. Keng. (2014). Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies. Seminars in Cell and Developmental Biology. 27. 86–95. 14 indexed citations
14.
Riordan, Jesse D., Vincent W. Keng, Barbara R. Tschida, et al.. (2013). Identification of Rtl1, a Retrotransposon-Derived Imprinted Gene, as a Novel Driver of Hepatocarcinogenesis. PLoS Genetics. 9(4). e1003441–e1003441. 70 indexed citations
15.
Keng, Vincent W., Adrienne L. Watson, Eric P. Rahrmann, et al.. (2013). Abstract 354: Conditional inactivation of Pten and overexpression of EGFR in Schwann cells results in early high-grade peripheral nerve sheath tumor development.. Cancer Research. 73(8_Supplement). 354–354. 2 indexed citations
16.
Keng, Vincent W., Eric P. Rahrmann, Adrienne L. Watson, et al.. (2012). PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors. Cancer Research. 72(13). 3405–3413. 67 indexed citations
17.
Keng, Vincent W., Daniela Sia, Aaron L. Sarver, et al.. (2012). Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR. Hepatology. 57(1). 120–130. 47 indexed citations
18.
Keng, Vincent W., Adrienne L. Watson, Eric P. Rahrmann, et al.. (2012). Conditional Inactivation ofPtenwithEGFROverexpression in Schwann Cells Models Sporadic MPNST. Sarcoma. 2012. 1–12. 27 indexed citations
19.
Keng, Vincent W., Barbara R. Tschida, Jason Bell, & David A. Largaespada. (2010). Modeling Hepatitis B Virus X–Induced Hepatocellular Carcinoma in Mice With the Sleeping Beauty Transposon System Δ. Hepatology. 53(3). 781–790. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026